has anyone had a good read of the chairmans address.
Whilst this board appears to be owning up to the facts some of the comments shows more delays are on the way.
Looks like the safety scaple is being pushed into the background- page 2 of his address states the their success is aligned to the success of their syringe. BUT they then go on to say there is no great urgency to obtain FDA. Now a one product company.
I would have thought that obtaining FDA approval was critical before moving ahead in the US market- no FDA approval, then no US market. You spend all this money to get into full production and if the FDA application fails what then- run out of money again.
Refer to my post on 14 September Preliminary Report possible share Plan- now November we have one.
If I is was still a holder(Sold out early October), would have reservations in taking up the placement.
Comments anyone
agm chairmans report
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OVT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
-0.001(6.25%) |
Mkt cap ! $17.03M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.8¢ | 1.4¢ | $252.5K | 16.38M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 2187714 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 433613 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| OVT (ASX) Chart |